Martin Pomper

Cancer Targeting Systems, Inc. offers cancer care. The firm focuses on delivering cancer theranostic products combining imaging with therapy. The company was founded by Martin Pomper and Will West and is headquartered in Boston, MA.

Plenary AI is a company that specializes in providing clinical staff with customized artificial intelligence tools to help them make more informed decisions for patients. The company is based in Gaithersburg, MD and was founded by Martin Pomper and Edward Herskovits. Plenary AI's team is led by world-class experts from leading biomedical research systems, including Johns Hopkins University and the University of Maryland Medical Center. The company's aim is to revolutionize precision health by combining relevant biomarkers and multi-modality imaging to put each patient's unique information against the backdrop of a vast amount of data analytics. Plenary AI has developed several products, including an automated screening, diagnostic, and prognostic assessment tool, a machine learning framework for cancer classification on PET images, and a machine learning framework for Parkinson's disease subtype selection. Edward Herskovits has been the CEO since incorporation.

Cancer Targeting Systems, Inc. offers cancer care. The firm focuses on delivering cancer theranostic products combining imaging with therapy. The company was founded by Martin Pomper and Will West and is headquartered in Boston, MA.